Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site)
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- 22 Jinqiao Road, Dapu Industrial Park, Economic and Technological Development Zone, Lianyungang, Jiangsu 222069, China (CHN)
- Operations here
- analysisapi manufacturelabelmanufacturepackparticle size reductionsterilize
- FDA identifiers
- FEI 3006689263 · DUNS 699507972
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-04-15
- VAIDrug Quality Assurance2018-04-13
- NAIDrug Quality Assurance2015-08-28
- NAIDrug Quality Assurance2013-09-10
- NAIDrug Quality Assurance2013-08-20
- NAIDrug Quality Assurance2012-08-01
Drugs this plant is listed as making
3 distinct drugs across 6 products name this site in their FDA label.
- BupivacaineJiangsu Hengrui Pharmaceuticals Co., Ltd.
- cyclophosphamideFresenius Kabi USA, LLC
- GadobutrolFresenius Kabi USA, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.